These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 18286870)

  • 1. Monitoring and management of metabolic risk factors in outpatients taking antipsychotic drugs: a controlled study.
    Jennex A; Gardner DM
    Can J Psychiatry; 2008 Jan; 53(1):34-42. PubMed ID: 18286870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
    Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
    Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening of cardiovascular risk factors in patients with schizophrenia and patients treated with antipsychotic drugs: are we equally exhaustive as with the general population?
    Castillo-Sánchez M; Fàbregas-Escurriola M; Bergè-Baquero D; Fernández-SanMartín M; Goday-Arno A
    Clin Exp Hypertens; 2017; 39(5):441-447. PubMed ID: 28590147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic monitoring for patients treated with antipsychotic medications.
    Cohn TA; Sernyak MJ
    Can J Psychiatry; 2006 Jul; 51(8):492-501. PubMed ID: 16933586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of monitoring for metabolic effects associated with second generation antipsychotics in patients with schizophrenia on public insurance.
    Moeller KE; Rigler SK; Mayorga A; Nazir N; Shireman TI
    Schizophr Res; 2011 Mar; 126(1-3):117-23. PubMed ID: 21168994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The METEOR study: frequency of metabolic disorders in patients with schizophrenia. Focus on first and second generation and level of risk of antipsychotic drugs.
    Falissard B; Mauri M; Shaw K; Wetterling T; Doble A; Giudicelli A; De Hert M
    Int Clin Psychopharmacol; 2011 Nov; 26(6):291-302. PubMed ID: 21876442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered metabolic parameters in association with antipsychotic medication use in diabetes: A population based case-control study.
    Wake DJ; Broughton P; Perera SM; MacIntyre DJ; Leese GP
    Psychoneuroendocrinology; 2016 Apr; 66():214-20. PubMed ID: 26849203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of developing diabetes and dyslipidemia among adolescents with bipolar disorder or schizophrenia.
    Enger C; Jones ME; Kryzhanovskaya L; Doherty M; McAfee AT
    Int J Adolesc Med Health; 2013; 25(1):3-11. PubMed ID: 23337048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medical risk in patients with bipolar disorder and schizophrenia.
    Newcomer JW
    J Clin Psychiatry; 2006 Nov; 67(11):e16. PubMed ID: 17201046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A predisposition for allergies predicts subsequent hypertension, dyslipidemia, and diabetes mellitus among patients with schizophrenia or bipolar disorder: a nationwide longitudinal study.
    Chen MH; Li CT; Lin WC; Wei HT; Chang WH; Chen TJ; Pan TL; Su TP; Bai YM
    Schizophr Res; 2014 Oct; 159(1):171-5. PubMed ID: 25115406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of diabetes mellitus among outpatients with severe mental disorders receiving atypical antipsychotic drugs.
    Lamberti JS; Crilly JF; Maharaj K; Olson D; Wiener K; Dvorin S; Costea GO; Bushey MP; Dietz MB
    J Clin Psychiatry; 2004 May; 65(5):702-6. PubMed ID: 15163259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Metabolic risk during antipsychotic treatment in patients with schizophrenia].
    Rzewuska M
    Psychiatr Pol; 2007; 41(4):457-72. PubMed ID: 18046977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of a point-of-care metabolic risk screening program in outpatients receiving antipsychotic agents.
    Schneiderhan ME; Batscha CL; Rosen C
    Pharmacotherapy; 2009 Aug; 29(8):975-87. PubMed ID: 19637951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gender differences in antipsychotics prescribed to veterans with serious mental illness.
    Schwartz E; Charlotte M; Slade E; Medoff D; Li L; Dixon L; Kilbourne A; Kreyenbuhl J
    Gen Hosp Psychiatry; 2015; 37(4):347-51. PubMed ID: 25936673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of the metabolic syndrome in Danish psychiatric outpatients treated with antipsychotics.
    Krane-Gartiser K; Breum L; Glümrr C; Linneberg A; Madsen M; Køster A; Jepsen PW; Fink-Jensen A
    Nord J Psychiatry; 2011 Oct; 65(5):345-52. PubMed ID: 21428861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and costs of cardiometabolic conditions in patients with schizophrenia treated with antipsychotic medications.
    Jerrell JM; McIntyre RS; Tripathi A
    Clin Schizophr Relat Psychoses; 2010 Oct; 4(3):161-8. PubMed ID: 20880826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of diabetes mellitus associated with atypical antipsychotic use among Medicaid patients with bipolar disorder: a nested case-control study.
    Guo JJ; Keck PE; Corey-Lisle PK; Li H; Jiang D; Jang R; L'Italien GJ
    Pharmacotherapy; 2007 Jan; 27(1):27-35. PubMed ID: 17192159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic risk factors among medicaid outpatients with schizophrenia receiving second-generation antipsychotics.
    Bell RC; Farmer S; Ries R; Srebnik D
    Psychiatr Serv; 2009 Dec; 60(12):1686-9. PubMed ID: 19952163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Psychiatrists' decision making and monitoring of antipsychotic prescription for elderly schizophrenia patients].
    Jalenques I; Ortega V; Legrand G; Auclair C
    Encephale; 2016 Apr; 42(2):124-9. PubMed ID: 26796558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring and Treating Metabolic Abnormalities in Patients with Early Psychosis Initiated on Antipsychotic Medications.
    Bozymski KM; Whitten JA; Blair ME; Overley AM; Ott CA
    Community Ment Health J; 2018 Aug; 54(6):717-724. PubMed ID: 29127566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.